Protagenic Therapeutics Stock Buy Hold or Sell Recommendation
| PTIXW Stock | USD 0.01 0 11.11% |
Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding Protagenic Therapeutics is 'Not Rated'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Protagenic Therapeutics given historical horizon and risk tolerance towards Protagenic Therapeutics. When Macroaxis issues a 'buy' or 'sell' recommendation for Protagenic Therapeutics, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. Note, we conduct extensive research on individual companies such as Protagenic and provide practical buy, sell, or hold advice based on investors' constraints. Protagenic Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
Protagenic |
Execute Protagenic Therapeutics Buy or Sell Advice
The Protagenic recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Protagenic Therapeutics. Macroaxis does not own or have any residual interests in Protagenic Therapeutics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Protagenic Therapeutics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Protagenic Therapeutics Trading Alerts and Improvement Suggestions
| Protagenic Therapeutics is not yet fully synchronised with the market data | |
| Protagenic Therapeutics is way too risky over 90 days horizon | |
| Protagenic Therapeutics has some characteristics of a very speculative penny stock | |
| Protagenic Therapeutics appears to be risky and price may revert if volatility continues | |
| Protagenic Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (5 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Protagenic Therapeutics has accumulated about 671.09 K in cash with (3.7 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.06, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Protagenic Therapeutics has a frail financial position based on the latest SEC disclosures |
Protagenic Therapeutics Returns Distribution Density
The distribution of Protagenic Therapeutics' historical returns is an attempt to chart the uncertainty of Protagenic Therapeutics' future price movements. The chart of the probability distribution of Protagenic Therapeutics daily returns describes the distribution of returns around its average expected value. We use Protagenic Therapeutics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Protagenic Therapeutics returns is essential to provide solid investment advice for Protagenic Therapeutics.
| Mean Return | 1.27 | Value At Risk | -41.67 | Potential Upside | 60.49 | Standard Deviation | 28.83 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Protagenic Therapeutics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Protagenic Therapeutics Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 436.1K | (127.5K) | (129.9K) | (326.0K) | 1.1M | 1.1M | |
| Free Cash Flow | (488.0K) | (1.3M) | (2.8M) | (2.0M) | (3.9M) | (3.7M) | |
| Depreciation | 339.0 | 286.0 | 427.1K | 30.0 | 28.2K | 26.8K | |
| Other Non Cash Items | 110.9K | 154.9K | 346.0K | 156.8K | 716.1K | 680.3K | |
| Net Income | (1.8M) | (2.5M) | (4.5M) | (3.6M) | (5.0M) | (5.3M) | |
| End Period Cash Flow | 798.6K | 671.1K | 541.2K | 215.2K | 1.3M | 1.2M | |
| Investments | 250K | 0.0 | (9.9M) | 1.6M | 2.7M | 2.8M |
Note: Acquisition by Musci Raymond of 1758 shares of Protagenic Therapeutics at 2.09 subject to Rule 16b-3 [view details]
Protagenic Therapeutics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Protagenic . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Protagenic Therapeutics Buy or Sell Advice
When is the right time to buy or sell Protagenic Therapeutics? Buying financial instruments such as Protagenic Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Protagenic Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Marijuana Thematic Idea Now
Marijuana
Small and mid-cap equities that are involved in production and delivery of Marijuana products. This theme is designed for investors that are willing to accept higher levels of market risk inherited by Marijuana production in the United States. The Marijuana theme has 49 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Marijuana Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Protagenic Stock Analysis
When running Protagenic Therapeutics' price analysis, check to measure Protagenic Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protagenic Therapeutics is operating at the current time. Most of Protagenic Therapeutics' value examination focuses on studying past and present price action to predict the probability of Protagenic Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protagenic Therapeutics' price. Additionally, you may evaluate how the addition of Protagenic Therapeutics to your portfolios can decrease your overall portfolio volatility.